Home Amines 1022150-12-4
1022150-12-4,MFCD09972163
Catalog No.:AA0006VT

1022150-12-4 | (R)-3-(4-Phenoxyphenyl)-1-(piperidin-3-yl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
98%
in stock  
$6.00   $4.00
- +
2mg
98%
in stock  
$7.00   $5.00
- +
10mg
98%
in stock  
$12.00   $8.00
- +
1g
98%
in stock  
$29.00   $21.00
- +
5g
98%
in stock  
$115.00   $81.00
- +
25g
98%
in stock  
$360.00   $252.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA0006VT
Chemical Name:
(R)-3-(4-Phenoxyphenyl)-1-(piperidin-3-yl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine
CAS Number:
1022150-12-4
Molecular Formula:
C22H22N6O
Molecular Weight:
386.4497
MDL Number:
MFCD09972163
SMILES:
Nc1ncnc2c1c(nn2[C@@H]1CCCNC1)c1ccc(cc1)Oc1ccccc1
Properties
Computed Properties
 
Complexity:
521  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Heavy Atom Count:
29  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
4  
XLogP3:
3.1  

Downstream Synthesis Route

[1]OrganicandBiomolecularChemistry,2015,vol.13,p.5147-5157

[2]Patent:WO2017/39425,2017,A1.Locationinpatent:Page/Pagecolumn7;8

[3]Patent:CN105622613,2016,A.Locationinpatent:Paragraph0109;0204;0205;0206;0207

[4]Patent:WO2017/137446,2017,A1.Locationinpatent:Page/Pagecolumn15

[5]Patent:CN104557945,2017,B.Locationinpatent:Paragraph0070;0071;0072;0074;0075

[6]Patent:WO2014/139970,2014,A1.Locationinpatent:Page/Pagecolumn19;25

[7]Patent:CN106146511,2016,A.Locationinpatent:Paragraph0153;0154;0155

[8]Patent:CN105399756,2016,A.Locationinpatent:Paragraph0155;0174-0176

[9]Patent:CN106188062,2016,A.Locationinpatent:Paragraph0082;0083;0084;0085;0086;0087

[10]Patent:US2008/214501,2008,A1.Locationinpatent:Page/Pagecolumn12

[11]Patent:WO2012/158795,2012,A1.Locationinpatent:Page/Pagecolumn77

[12]Patent:WO2013/191965,2013,A1.Locationinpatent:Page/Pagecolumn157

[13]Patent:WO2014/22569,2014,A1.Locationinpatent:Page/Pagecolumn50

[14]Patent:US8673925,2014,B1.Locationinpatent:Page/Pagecolumn201

[15]JournalofMedicinalChemistry,2015,vol.58,p.9625-9638

[16]Patent:WO2017/163257,2017,A1.Locationinpatent:Page/Pagecolumn19

[17]Patent:CN106008526,2016,A.Locationinpatent:Paragraph0016;0063;0064;0065

[18]Patent:CN109232581,2019,A.Locationinpatent:Paragraph0014

1022150-13-5    1022150-12-4   
C37H47N9O4 

[1]Patent:US2008/214501,2008,A1.Locationinpatent:Page/Pagecolumn13

[1]Patent:WO2012/158795,2012,A1

[2]Patent:WO2013/191965,2013,A1

[3]Patent:WO2013/191965,2013,A1

[4]Patent:WO2014/22569,2014,A1

[5]Patent:WO2014/22569,2014,A1

[6]Patent:US8673925,2014,B1

[7]Patent:US8673925,2014,B1

[8]Patent:WO2014/176348,2014,A1

[9]OrganicandBiomolecularChemistry,2015,vol.13,p.5147-5157

[10]JournalofMedicinalChemistry,2015,vol.58,p.9625-9638

[11]Patent:CN105859728,2016,A

[12]Patent:CN105399756,2016,A

[13]Patent:CN106146511,2016,A

[14]Patent:CN104557945,2017,B

[1]Patent:WO2012/158795,2012,A1

[2]Patent:WO2013/191965,2013,A1

[3]Patent:WO2013/191965,2013,A1

[4]Patent:WO2014/22569,2014,A1

[5]Patent:WO2014/22569,2014,A1

[6]Patent:US8673925,2014,B1

[7]Patent:US8673925,2014,B1

[8]Patent:WO2014/176348,2014,A1

[9]OrganicandBiomolecularChemistry,2015,vol.13,p.5147-5157

[10]JournalofMedicinalChemistry,2015,vol.58,p.9625-9638

[11]Patent:CN105859728,2016,A

[12]Patent:CN105399756,2016,A

[13]Patent:CN104557945,2017,B

[14]Patent:CN109111446,2019,A

[1]Patent:WO2012/158795,2012,A1

[2]Patent:WO2013/191965,2013,A1

[3]Patent:WO2014/22569,2014,A1

[4]Patent:US8673925,2014,B1

[5]Patent:CN106146511,2016,A

[6]Patent:CN104557945,2017,B

Literature

Title: Somana Siva Prasad, et al. A QUALITY BY DESIGN APPROACH FOR DEVELOPMENT OF SIMPLE AND ROBUST REVERSED PHASE STABILITY INDICATING HPLC METHOD FOR ESTIMATION OF IBRUTINIB AND ITS IMPURITIES.

Title: Honigberg LA, et al. The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy. Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13075-80.

Title: Liu N, et al. Direct and two-step bioorthogonal probes for Bruton's tyrosine kinase based on ibrutinib: a comparative study. Org Biomol Chem. 2015 May 14;13(18):5147-57.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1022150-12-4 Molecular Formula|1022150-12-4 MDL|1022150-12-4 SMILES|1022150-12-4 (R)-3-(4-Phenoxyphenyl)-1-(piperidin-3-yl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine